UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. (2018)
Attributed to:
Characterising and targeting aberrant enhancer function in acute myeloid leukaemia (AML)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41588-018-0114-z
PubMed Identifier: 29736013
Publication URI: http://europepmc.org/abstract/MED/29736013
Type: Journal Article/Review
Volume: 50
Parent Publication: Nature genetics
Issue: 6
ISSN: 1061-4036